Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer

  1. Pompas-Veganzones, N.
  2. Sandonis, V.
  3. Perez-Lanzac, A.
  4. Beltran, M.
  5. Beardo, P.
  6. Juárez, A.
  7. Vazquez, F.
  8. Cozar, J.M.
  9. Alvarez-Ossorio, J.L.
  10. Sanchez-Carbayo, M.
Revue:
Tumor Biology

ISSN: 1423-0380,  1010-4283

Année de publication: 2016

Volumen: 37

Número: 10

Pages: 14301-14310

Type: Article

DOI: 10.1007/S13277-016-5267-8 GOOGLE SCHOLAR
La source de données: Scopus